Phio Pharmaceuticals Corp.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 13, 2026 FORM 8-K
4 Sep 30, 2026
4 Sep 29, 2026
4 Sep 29, 2026
4 Sep 29, 2026
S-8 Sep 28, 2026 FORM S-8
8-K Sep 28, 2026 FORM 8-K
4 Sep 25, 2026
4 Sep 23, 2026
4 Sep 16, 2026
4 Sep 15, 2026
4 Sep 15, 2026
8-K Sep 14, 2026 FORM 8-K
4 Aug 20, 2026
4 Aug 19, 2026
ARS Aug 14, 2026 ANNUAL REPORT
DEFA14A Aug 14, 2026 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
DEF 14A Aug 14, 2026 FORM DEF 14A
8-K Aug 6, 2026 FORM 8-K
10-Q Aug 6, 2026 FORM 10-Q
3 Jul 30, 2026
8-K Jul 21, 2026 FORM 8-K
4 Jun 29, 2026
10-Q May 7, 2026 FORM 10-Q
8-K May 7, 2026 FORM 8-K
← Newer Page 1 of 36 · 892 filings Older →